Manufacture of pharmaceutical preparations
VISTIN PHARMA ASA
Operating profit
NOK −6.1m
Equity
NOK 184.0m
Incorporated
2015
Share capital
NOK 44.3m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 6.1m | |
| Operating profit (EBIT) | −6.1m | |
| Net financial items | 1.5m | |
| Profit for the year | −3.5m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 186.6m | |
| of which current assets | 131.7m | |
| Equity | 184.0m | |
| Total liabilities | 2.6m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.